StockpollyBeta
Get App
Popularity #1,660
AXGN · NASDAQ · Medical - Devices

Axogen (AXGN)

Supplies nerve grafts and protective implants for surgical peripheral nerve repair.

$44.45
After-hours close−0.11 (−0.25%)
At close$44.56(−2.98%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue414341484949495760606170
Cost of revenue1099131212141514151519
Gross profit323433353638354246444651
363737363736374044544953
Research & development7777776781289
293030293029313337424244
Selling & marketing192220201920212426272931
General & administrative10710911991011151313
Other expenses000000000000
Operating income−4−3−5002−222−10−3−2
0−1−2−1−2−2−2−1−1−3−171
Interest income000000000001
Interest expense1222222210210
Other non-operating income−1−10−1000−1−92160
Income before tax−4−4−7−2−20−411−13−20−2
Net income from continuing operations−4−4−7−2−20−411−13−20−2
Net income−4−4−7−2−20−411−13−20−2
EPS, basic−$0.10−$0.09−$0.15−$0.04−$0.04$0.01−$0.08$0.01$0.02−$0.28−$0.38−$0.03
EPS, diluted−$0.10−$0.09−$0.15−$0.04−$0.04$0.01−$0.08$0.01$0.01−$0.28−$0.38−$0.03
Weighted average shares, basic434343444445454646475253
Weighted average shares, diluted434343444448454646475253
EBITDA−20−22240413−8−17−2
Depreciation & amortization122222222320
EBIT−3−2−4002−2311−11−19−2